8-KEarnings & ResultsRegulation FDExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (Jan 8, 2024)

Filed January 8, 2024For Securities:GH

Summary

Guardant Health, Inc. (GH) filed an 8-K on January 8, 2024, to announce preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2023. While the filing itself does not contain the specific financial figures, it states that a press release with this information has been furnished as an exhibit. Investors should refer to Exhibit 99.1 for the detailed preliminary financial results, which will be crucial for assessing the company's recent performance and future outlook. Additionally, the company indicated that a presentation for the 2024 J.P. Morgan Healthcare Conference, also scheduled for January 8, 2024, would be made available on their investor website. This presentation may offer further insights into the company's strategy, operational updates, and financial projections. It's important to note that the information furnished in this report is not considered 'filed' for regulatory purposes, meaning it doesn't carry the same liability implications as formally filed financial statements.

Key Highlights

  • 1Guardant Health announced preliminary, unaudited financial results for Q4 and full-year 2023 via an 8-K filing.
  • 2The detailed financial results are available in the press release furnished as Exhibit 99.1.
  • 3The company is participating in the 2024 J.P. Morgan Healthcare Conference on January 8, 2024.
  • 4A presentation for the J.P. Morgan Healthcare Conference will be posted on the Guardant Health investor website.
  • 5The information provided in this 8-K is furnished, not filed, and is subject to Regulation FD disclosure rules.

Frequently Asked Questions

The actual preliminary financial results for the quarter and full year ended December 31, 2023, are detailed in the press release furnished as Exhibit 99.1 to this Form 8-K filing. Investors should review this exhibit for specific figures.

Presenting at a major healthcare conference like the J.P. Morgan Healthcare Conference provides Guardant Health an opportunity to update investors on its business, strategy, and financial performance. Details from this presentation, if material, will likely be shared on their investor relations website.

When information is 'furnished' under Item 2.02 or 7.01 of an 8-K, it is made public but does not carry the same legal liability as if it were 'filed' under Section 18 of the Exchange Act. It is typically to comply with Regulation FD disclosure requirements. However, it's still important information for investors to consider.